Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Azithromycin in Control of Trachoma II

This study has been withdrawn prior to enrollment.
(Prevalence of infection for screened population too low (<7%) to enroll anyone.)
Sponsor:
Collaborator:
National Institute of Allergy and Infectious Diseases (NIAID)
Information provided by (Responsible Party):
Julius Schachter, University of California, San Francisco
ClinicalTrials.gov Identifier:
NCT00286026
First received: January 31, 2006
Last updated: April 12, 2012
Last verified: April 2012
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Study Status: This study has been withdrawn prior to enrollment.
  Study Completion Date: August 2009
  Primary Completion Date: August 2007 (Final data collection date for primary outcome measure)